ACER3 and fatty liver disease: H&E and ORO staining failed to find any significant difference in the area of steatosis in liver between Acer3−/− and Acer3+/+ mice (Fig. 2c, e), indicating that Acer3 deficiency does not impact the diet-induced hepatic steatosis.